ANDREW SHEHATA: Open Payments
NPI 1669096574 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 30 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $462 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $153 |
| Phathom Pharmaceuticals, Inc. | 7 | $70 |
| Ardelyx, Inc. | 3 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $35 |
| Janssen Biotech, Inc. | 2 | $35 |
| Celltrion USA Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REZDIFFRA, VOQUEZNA, IBSRELA, ENTYVIO, Wegovy, TREMFYA, VEGZELMA, CREON.
Industry payments across NJ — which companies pay providers there.
